Camilla Huse Bondesson
Director/Miembro de la Junta en GENETIC ANALYSIS .
Origen de la red de primer grado Camilla Huse Bondesson.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
19
| Public Company | Medical Specialties | 19 |
| Public Company | Medical Specialties | 12 | |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.
11
| Private Company | Pharmaceuticals: Major | 11 |
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden.
8
| Holding Company | Medical Specialties | 8 |
Conlega AB
 Conlega AB Miscellaneous Commercial ServicesCommercial Services Conlega operates as a consulting firm specializing in bio business. Its services include interim management, business coaching, board assignments and commercialization of new products. The company was founded by Paula Zeilon and Margaretha Gadnell in 2001 and is headquartered in Lund, Sweden.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Camilla Huse Bondesson a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC. | Medical Specialties | Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Sales & Marketing | |
| CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Corporate Officer/Principal | |
| SYSMEX CORPORATION | Medical Specialties | Corporate Officer/Principal | |
| AMBU A/S | Medical Specialties | Director/Board Member | |
| BIOGAIA AB | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Stockholm | College/University | Doctorate Degree Masters Business Admin | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| University of Lund | College/University | Graduate Degree | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
| Amersham Pharmacia Biotech Corp. | Sales & Marketing | ||
| University of Gothenburg | College/University | Doctorate Degree | |
Lophius Biosciences GmbH
 Lophius Biosciences GmbH Medical/Nursing ServicesHealth Services Lophius Biosciences GmbH develops and markets T-cell-based diagnostic test systems. The firm specializes in the development of products for the diagnosis and immuno monitoring of virus-specific immune responses. It also provides customized services in the field of cell-based bioactivity, as well as quality tests for pharmaceutical active substances. The firm focuses on improving therapy control and personalized treatment of patients in the area of transplantation medicine and infectious and autoimmune diseases. The company was founded by Ludwig Deml and Fritz Schwarzmann in 2002 and it is headquartered in Regensburg, Germany. | Medical/Nursing Services | Chief Executive Officer | |
DELTA A/S (Denmark)
 DELTA A/S (Denmark) Miscellaneous Commercial ServicesCommercial Services DELTA A/S is a testing and consulting private company based in Hørsholm, Denmark. DELTA A/S operates as a testing and consulting Danish company. The CEO of the company is Per Hartlev. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| Danish National Research Foundation | Director/Board Member Corporate Officer/Principal | ||
| Invitrogen AB | Sales & Marketing | ||
| European Organisation for Research & Treatment of Cancer | Director/Board Member | ||
| GUARD THERAPEUTICS INTERNATIONAL AB | Pharmaceuticals: Major | Director/Board Member | |
DELTA, Dansk, Elektronik, Lys & Akustik
 DELTA, Dansk, Elektronik, Lys & Akustik Miscellaneous Commercial ServicesCommercial Services DELTA, Dansk, Elektronik, Lys & Akustik offers technical consultancy services in the fields of electronics, microelectronics, software technology, light, optics, acoustics, vibration and sensor systems. The company was founded by P.O. Pedersen in 1941 and is headquartered in Horsholm, Denmark. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| Sino Danish Breast Cancer Research Centre | Director/Board Member | ||
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Pharmaceuticals: Major | Chairman | |
| Delta Reader A/S | Chairman Chairman | ||
Gradientech AB
 Gradientech AB BiotechnologyHealth Technology Gradientech AB operates as biotech and diagnostics company. It develops and provides ultra-rapid antibiotic susceptibility testing products. The company's products include QuickMic, CellDirector and Tracking Tool PRO. Gradientech was founded by Sara Ulrika Thorslund and Johan Kreuger in 2009 and is headquartered in Uppsala, Sweden. | Biotechnology | Chairman | |
OnTarget Chemistry AB
 OnTarget Chemistry AB BiotechnologyHealth Technology Part of Recipharm AB, OnTarget Chemistry AB provides research services for medicinal synthesis and pharmaceutical products. The company is based in Uppsala, Sweden. OnTarget Chemistry was acquired by Recipharm AB on June 15, 2015 for $1.85 million. | Biotechnology | Chief Executive Officer | |
HepaRegeniX GmbH
 HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
Iota Sciences Ltd.
 Iota Sciences Ltd. Packaged SoftwareTechnology Services Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Chief Executive Officer | |
NTP Nano Tech Projects SRL
 NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy. | Miscellaneous Commercial Services | Chairman | |
Magenta Capital UG (haftungsbeschränkt)
 Magenta Capital UG (haftungsbeschränkt) Miscellaneous Commercial ServicesCommercial Services Magenta Capital UG (haftungsbeschränkt) is a private company based in Potsdam, Germany. The German company provides business and economic services. | Miscellaneous Commercial Services | Chairman | |
| WireOnAir A/S | Director/Board Member | ||
JHO Holding ApS
 JHO Holding ApS Financial ConglomeratesFinance JHO Holding ApS provides financial intermediation services. | Financial Conglomerates | Director/Board Member | |
Recipharm OT Chemistry AB
 Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Noscendo GmbH
 Noscendo GmbH Medical SpecialtiesHealth Technology Noscendo GmbH is a diagnostics company, which engages in the identification and assessment of bloodstream-associated pathogens and other infections. It offers logistics, sample preparation, sequencing, data analysis, and reports. The company was founded by Philip Stevens, Silke Grumaz and Kai Sohn and is headquartered in Duisburg, Germany. | Medical Specialties | Director/Board Member | |
HC Andersen Capital ApS
 HC Andersen Capital ApS MiscellaneousMiscellaneous HC Andersen Capital ApS functions as an investment holding Danish company. The private company is based in Copenhagen, Denmark. The company was founded in 2020. Tue Østergaard has been the CEO of the company since 2020. | Miscellaneous | Chairman | |
| OT Pharmaceuticals AB | Chief Executive Officer | ||
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Sysmex Europe SE
 Sysmex Europe SE Medical SpecialtiesHealth Technology Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany. | Medical Specialties | Corporate Officer/Principal |
Estadísticas
Internacional
| Suecia | 20 |
| Dinamarca | 17 |
| Alemania | 7 |
| Estados Unidos | 3 |
| Noruega | 3 |
Sectorial
| Health Technology | 19 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Finance | 3 |
| Miscellaneous | 3 |
Operativa
| Director/Board Member | 150 |
| Corporate Officer/Principal | 49 |
| Chairman | 49 |
| Chief Executive Officer | 44 |
| Founder | 27 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Kathryn Moore Baker | 45 |
| Jørgen Drejer | 26 |
| Rune Sørum | 21 |
| Povl-André Bang Bendz | 19 |
| Nils Aage Brünner | 17 |
| Fredrik Lehmann | 17 |
| Lars Olov Jonsson | 16 |
| Tonni Bülow-Nielsen | 15 |
| Paula Zeilon | 14 |
| Juan Farré | 13 |
| Staffan Strömberg | 11 |
| Simon Hesse Hoffmann | 10 |
| Jörgen Lönngren | 9 |
| Ole Thastrup | 9 |
| Ronny Hermansen | 8 |
- Bolsa de valores
- Insiders
- Camilla Huse Bondesson
- Conexiones Empresas
